FIELD: organic chemistry, chemical technology, pharmacy.
SUBSTANCE: invention relates to a method for preparing 6-substituted derivatives of 2-(alkylsulfanyl)-4(3H)-pyrimidinone of the general formula (I) that are used as intermediate products for synthesis of medicinal preparations and as independent medicinal preparations. In compounds of the formula (I),
R means C6H5CH2; R' means CH3, CH(CH3)C2H5, cyclo-C5H9, cyclo-C6H11; R means 2,6-F2C6H3CH2; R' means CH3, CH(CH3)C2H5, cyclo-C5H9, cyclo-C6H11; R means 2,6-Cl2C6H3CH2; R' means CH3, CH(CH3)C2H5, cyclo-C5H9, cyclo-C6H11; R means 1-C10H7CH2; R' means CH3, CH(CH3)C2H5, cyclo-C5H9, cyclo-C6H11; R means Ph2CH; R' means CH3, C2H5, CH(CH3)C2H5, cyclo-C5H9, C6H11. Method involves the following reactions. S-Alkylisothiourea hydrohalogen taken among the group: S-methylisothiourea hydroiodide, S-ethylisothiourea hydrobromide, S-sec.-butylisothiourea hydrobromide, S-cyclopentylisothiourea hydrobromide or S-cyclohexylisothiourea hydrobromide prepared into reactor directly (in situ) from thiourea and corresponding halogenalkane or sec.-butanol or cycloalkanol in the presence hydrobromic acid is subjected for interaction with 4-aryl-3-oxobutanoic acid methyl ester or 4,4-diaryl-3-oxobutanoic acid methyl ester in ethanol solution in the presence of potassium carbonate an aqueous solution wherein indicated methyl esters of acid are taken among the following group: 4-phenyl-3-oxobutanoic acid methyl ester, 4-(2,6-difluorophenyl)-3-oxobutanoic acid methyl ester, 4-(2,6-dichlorophenyl)-3-oxobutanoic acid methyl ester, 4-(1-naphthyl)-3-oxobutanoic acid methyl ester and 4,4-diphenyl-3-oxobutanoic acid methyl ester in the mole ratio 4-aryl-3-oxobutanoic acid methyl ester or 4,4-diaryl-3-oxobutanoic acid methyl ester : S-alkylisothiourea hydrohalogen : potassium carbonate = (1:1)-(3:1)-3, respectively, and the following isolation of the end product. Invention provides enhancing yield of claimed compounds, simplified process in preparing and isolating end products.
EFFECT: improved preparing method.
22 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SYNTHESIS OF ETHYL ETHERS OF 2-ALKYL-4-ARYL-3-OXOBUTANOIC ACIDS | 2009 |
|
RU2412154C1 |
METHOD FOR THE OBTAINMENT OF 2-ALKOXY-6-[1-(2,6-DIFLUOROPHENYL)CYCLOPROPYL]-5-METHYLPIPERIMIDINE-4(3H)-ON | 2017 |
|
RU2654067C1 |
METHOD OF PRODUCING DERIVATIVES OF N2-ALKYL- AND N2,N2-DIALKYLISOCYTOSINE | 2017 |
|
RU2664121C1 |
METHOD OF PRODUCING Α-DIAZOCARBONYL COMPOUNDS IN AQUEOUS MEDIUM | 2018 |
|
RU2686489C1 |
DERIVATIVES OF 1,2,3,4-TETRAHYDRONAPHTHALENE, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF TREATMENT | 1998 |
|
RU2194696C2 |
METHOD OF SYNTHESIS OF L-CARNOSINE ESTERS AND THEIR SALTS | 2001 |
|
RU2188204C1 |
DERIVATIVES OF QUINOLINE XANTHINE AND 8-ISOQUINOLINE XANTHINE AS INHIBITORS OF PHOSPHODIESTERASE PDE-5 | 2001 |
|
RU2269529C2 |
METHOD OF OBTAINING ETHYL ESTER OF 2-METHYL-3-OXO-4-(2,6-DIFLUOROPHENYL)PENTANOIC ACID | 2012 |
|
RU2490252C1 |
COMPOUNDS AND METHODS FOR URIC ACID REDUCTION | 2009 |
|
RU2501554C2 |
BORONIC ACID DERIVATIVES | 2015 |
|
RU2717558C2 |
Authors
Dates
2004-10-20—Published
2003-04-21—Filed